SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001485003-21-000159
Filing Date
2021-07-21
Accepted
2021-07-21 17:39:35
Documents
4
Period of Report
2021-07-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_162690356027307.html 3  
1 FORM 3 wf-form3_162690356027307.xml 3 1722
2 MICHAEL JEWETT POA sesn-poaformjewettconfor.htm EX-24 4147
3 JEWETT - JPEG 1 sesn-poaformjewettconfor001.jpg GRAPHIC 221040
4 JEWETT - JPEG 2 sesn-poaformjewettconfor002.jpg GRAPHIC 59718
  Complete submission text file 0001485003-21-000159.txt   394253
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SESEN BIO, INC. 245 FIRST STREET, SUITE 1800 CAMBRIDGE MA 02142
Business Address
Jewett Michael A. S. (Reporting) CIK: 0001873730 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36296 | Film No.: 211105397